chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 1410 c/o throat itching, Benadryl 25mg PO administered. BP 139/90, P 70, )2 99% (room air), R 26. At 1415 BP 121/84, P 66, O2 99% (RA), R 20. At 1420 BP 128/56 P 62, O2 98% (RA) R 16. At 1430 BP 117/76, P 64, O2 99% (RA), R 16. Patient states he feels better, minimal itchiness present. 1438 pt discharged home.
Fever (4+ days), sweating (4+ days), chills (4+ days), nausea (2 days), headache (2 days), sore joints (4+ days), skin hurt (3 days), fatigue (4+ days), stuffy nose (2 days), sneezing (1 day)
rash is itchy, nonpainful. Took Chlortab this am with no improvement in sxs. No SOB/no itchy throat.
Redness, pain at injection site, tenderness and blisters present. (Right arm).
Patient said that right arm became very sore, tender, and swollen to a point where she was not able to lift her arm upon the 2nd day and has lasted for over a week. Noticed a bruise at the site of injection. Started taking naproxen to alleviate the pain and went to see chiropractic Dr. on 8/27 & 8/28 and was diagnosed with tendonitis. As of today, patient is able to lift arm, but cannot reach behind her back.
headache; stuffy nose; fever; sweating; ears blocked; sore arm; shingles; felt like a car ran me over; This is a spontaneous report from a contactable consumer or other non hcp.   A 64-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 05May2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation  .  The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient experienced headache (headache) (non-serious) on an unspecified date with outcome of unknown , stuffy nose (nasal congestion) (non-serious) on an unspecified date with outcome of unknown , fever (pyrexia) (non-serious) on an unspecified date with outcome of unknown , sweating (hyperhidrosis) (non-serious) on an unspecified date with outcome of unknown , ears blocked (ear discomfort) (non-serious) on an unspecified date with outcome of unknown , sore arm (limb discomfort) (non-serious) on an unspecified date with outcome of unknown , shingles (herpes zoster) (non-serious) on an unspecified date with outcome of unknown.  The action taken in response to the event(s) for bnt162b2 was not applicable.  Therapeutic measures were taken as a result of , shingles (herpes zoster).
About 10 minutes after vaccine the patient collapsed and had shallow breathing and only semi-alert. Called 911 and had her taken to Emergency Room.
improperly stored vaccine administered; no adverse effect; This spontaneous report was received from a medical assistant refers to a 4 months old patient of unknown gender.    The patient's medical history, concurrent conditions and concomitant medications were unknown. On 11-NOV-2019, the patient was vaccinated with improperly stored (product storage error) rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (therapy type: digital data logger) (lot # S005874 exp.date: 31-OCT-2020) for prophylaxis. The vaccine was under went at a temperature of 33.8 Fahrenheit for a time frame of 4 hours and 5 minutes. There is no previous temperature excursion. No adverse events were reported. No product quality compliant was reported.  The outcome of product storage error and no adverse event was unknown.
I basically got pretty massive ear infection in left ear that I just never get. It was also coupled with a lot of fatigue. It was significant fatigue. I went to Urgent Care and the Doctor prescribed ear drops - steroid antibiotic. That helped a bit with the symptoms. I still have it. I followed up with my doctor. He said there is no remaining infection but there is still tinnitus. The tinnitus in left ear is still there. I still have to finish off the medicine and I'm doing that.   Immediate - health event after the vaccine was received - I reacted pretty badly at first. It was a significant immune response. I got pretty sick for three days. Enough to not be able to go to work. And then those were gone after that time as expected.
The evening of the shot she had pain at injection site.  The following morning, had difficulty breathing, and tongue swelling.
This case was reported by a nurse and described the occurrence of vaccine underdose in a female patient who received HAVRIX PEDIATRIC (batch number 3J9AM, expiry date 5th September 2016. On an unknown date the patient received HAVRIX PEDIATRIC. On an unknown date, an unknown time after receiving HAVRIX PEDIATRIC, the patient experienced vaccine underdose. On an unknown date, the outcome of the vaccine underdose was unknown.
sore at injection site; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 18th March 2022, the patient received Shingles vaccine. In March 2022, less than a week after receiving Shingles vaccine, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received shot on Friday on an unknown arm.  The patient got covered 100 percent by insurance.  The patient experienced just a sore arm at injection site. The follow-up would not possible as no contact details were available.
aching @ site of inj several days p/vax;9x12 cm raised warm itchy area lt deltoid began 8DEC97 small hives seen w/in raised area;
child was inadvertently administered a dose of PROQUAD instead of the sheduled varicella vaccine; child was administered PROQUAD concomitantly with M-M-R II; This spontaneous report as received from a medical assistant refers to a child patient of unknown age and gender. On 06-AUG-2021, the patient was inadvertently vaccinated with a 0.5 mL dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (Lot # T034610 exp date 10-APR-2022) instead of the scheduled varicella virus vaccine live (oka/merck) (manufacturer unknown). The medical assistant also reported that the patient received a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (dose, route and lot # not reported) on the same date. Concomitant therapies included sterile diluent.
FUNNY CHEST PAIN; PAIN ON NECK VEINS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced funny chest pain, and pain on neck veins. Laboratory data (dates unspecified) included: Laboratory test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chest pain, and pain on neck veins. This report was non-serious.
This is a spontaneous report from a contactable physician. A 34-year-old female healthy patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration about a week ago before this report (in 2017) at single dose for immunization. Medical history and concomitant drug were unknown. Patient developed painful cysts or pustules filled with white stuff, almost like little acne.  It initially started at the injection site, and subsequently it moved to her chest, legs and arms. It was pretty painful. It was reported that the events started on the same day she received the vaccine (in 2017). The patient was in physician's office and she would like to know what it is and what she should do about them. Event outcome was unknown.
Date the vial was initially stored in the refrigerator: 30MAR2021, Date(s) of administration of vaccine : 23-May-2022; Received expired vaccine beyond the 30 day refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator :  30MAR2021, Date(s) of administration of vaccine : 23-May-2022) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator :  30MAR2021, Date(s) of administration of vaccine : 23-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator :  30MAR2021, Date(s) of administration of vaccine : 23-May-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported. The vial was initially stored in the refrigerator on 30-MAR-2021. The vial did not undergo any temperature excursions. The patient received second booster dose. No treatment drug was reported.
sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick). At the time of the report, ILLNESS (sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Nov-2021: Follow-up information received on 09-NOV-2021 contains non-significant information.
Unclear if this is related to vaccine contents itself or simply just due to the receipt of an injection.   While waiting to check out after vaccination, patient became diaphoretic and lightheaded and fell, possibly hitting head.  Found to be hypotensive.  Was observed in Urgent Care and discharged without further issue.
Patient presented with pleuritic chest pain on 4/12/21 and was diagnosed with multiple pulmonary embolisms. He was treated with heparin drip and discharged on Eliquis.
At ~ 3:00 pm next day heart palpitations started, Heart would beat normal then a sudden hard beat, It kept this up the remainder of the day till Monday 5/3/21 at around 9:00 am. Most of the weird heart beat was standing or binding over, Sitting position was better.
had a terrible headache; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (had a terrible headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (had a terrible headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown and IBUPROFEN (MOTRIN IB) at an unspecified dose and frequency. At the time of the report, HEADACHE (had a terrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had no reaction from the first, and had a terrible headache after the second dose.
Extreme Vertigo and Dizziness 20 minutes following vaccination. Patient began to slowly feel better.
Information has been received from a physician concerning a 24 weeks old female patient who on approximately 01-DEC-2008 was vaccinated with first dose of ROTATEQ (lot# not reported). On 24-MAR-2009 she received second dose of ROTATEQ (lot# not reported). The child was no experiencing any known symptoms. Additional information has been requested.
patient began running a fever day 1 after vaccination, this exacerbated a seizure, he was admitted to the hospital on 3/13/21 and stayed in a coma until his death
nauseau; vs: 127/77   rr-30  hr-117  o2 sat 100% 15 min recheck hr-91 1425 no further problems
The patient came to the pharmacy to report that since the date of the immunizations he did not feel good. He said that his arms were still sore and that they did not feel good when hanging by his side. He said it felt better to keep his arms crossed. He was asking if this was a normal side effect from having 3 immunizations on the same day.
Pt recvd 4th dose of Hep B & immed following vax devel severe burning pain @ inject site, & generalized weakness & began to perspire; also was pale but did not faint; w/in 6 to 8 mins recovered;
Pt returned and was turned away for their second dose of COVID on 5/19.  Pt indicated that they had hives after the first dose of COVID on 4/21.
Site: Bruising at Injection Site-Severe, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium.
Presented to urgent care on 4/10/21 with fever, chills, weakness, and cough. Was tested for COVID-19 and diagnosed with pneumonia. Patient then presented to ED on 4/11/21 with the same symptoms and was admitted to hospital for further care.
He had loss of taste; He had loss of Smell; tested for COVID-19 and unfortunately,he tested positive; This is a spontaneous report from a contactable consumer(patient himself) received from a Pfizer sponsored program.  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported) via an unspecified route of administration on 08Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. For about a week and a half, he had side effects. Last Saturday (March 20th) he had loss of taste and smell. So he decided to get tested for COVID-19 and unfortunately, he  was tested positive on 20Mar2021. He wants to know if he is contagious and since he had received the first dose, would that cut down the ability to spread the virus. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on unspecified date. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Tingling L shoulder at site of injection started one month after shot. Tingling happens at night a few times a week. Neg swelling and no other pain.
Case number PHEH2016US011972 is an initial spontaneous case received from nurse on 11 May 2016. This report refers to a 54 year old male patient. Medical history and concomitant medication were not reported. The patient was vaccinated with expired FLUCELVAX (batch number: 173253, expiry date: 30 Apr 2016) intramuscularly in left arm at a dose of 0.5 ml on 10 May 2016. No adverse event was reported following this medication error. Follow up information was received from a nurse on 23 Jun 2016. Added information included anatomical site of vaccination. Updated narrative accordingly.
Patient said his arm muscle at the injection site sore, suggested to use TYLENOL OTC.
pt recv vax 17JAN97 & approx 1.5hr later pt devel a severe h/a & fever;tx w/anti-fever meds & recovered;
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 05-MAY-2017, the patient was inadvertently vaccinated with an expired single dose of M-M-R II with lot # M032153 and expiration date of 22-APR-2017, subcutaneously (strength and dose were unknown) for prophylaxis. No adverse effects were reported. Additional information is not expected as no permission to contact was provided.
Recieved shot at 11am  weakness in right leg  at 2pm  started chiils no fever  blood sugar fell rapidly  to low in 50s by 4pm  blood pressure escalated to 197 over 91  nauseated  pain in right leg continued  called 911
skin r thigh Erythemic rash with few vesicles initial and put on KEFLEX 250mg for 10 days.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with the fist dose of GARDASIL (route and lot # unknown) and experienced a headache after receiving the vaccine. The patient sought medical attention by contacting the physician. At the time of the report the patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
Immediately felt a pop, pain and bubble sensation in shoulder joint. Within 3 hours I had decreased range of motion and it continued to decrease until I hardly any use of left arm without significant pain.
diabetes; This case was reported by a nurse via call center representative and described the occurrence of diabetes in a 8-year-old female patient who received Rabies NVS (RabAvert) for prophylaxis.   In October 2018, the patient received RabAvert. On 24th November 2019, less than 2 years after receiving RabAvert, the patient experienced diabetes (serious criteria GSK medically significant). On an unknown date, the outcome of the diabetes was unknown.   It was unknown if the reporter considered the diabetes to be related to RabAvert.  Additional details were provided as follows: It was unknown if the patient received Rabavert vaccine for pre or post exposure prophylaxis.  The patient was diagnosed with diabetes on 24th November 2019. The reporter was questioning whether the company had seen any correlation between diabetes and Rabavert. The case has been linked to the case US2019234437, reported by same reporter.
Followed up with our clinic on 4/1/2021 after hospital admission for sepsis, pancreatitis, and cholycystitis. Admitted to medical center on March 23rd, discharged home March 27th. Was seen at a smaller facility close to home, Medical Center, prior to adimission to . Pt states he was admitted to the ICU. We have not yet received copies of his medical records from admissions for additional information on presenting symptoms or labs. No previous hx of pancreatitis or cholycystitis. Pt was ambulatory and without acute complaints of abd pain, chest pain, or dyspnea at the time of his office follow-up. Reported to our providers that he was advised to have surgical follow-up for cholycystectomy within 1-2 weeks. No surgery while admitted.
Patient has been experiencing arm soreness/pain described as being more in the muscle than the shoulder since the vaccination occurred. Patient has been doing exercises and has seen her MD regarding the soreness. Has not improved significantly with time.
Fever > 100.5 for 30 hours with highest temp 103.0, treated with Tylenol 1000mg po q6h with poor effect. Muscle aches, treated with Ibuprofen 400mg 2 tabs po q6h prn, mild relief in muscle pain. Vomiting, 1 episode. Resting tachycardia, HR of 120 while supine lasting approximately 24 hours.
she has missed her second vaccination of GARDASIL 9; No adverse reactions reported; This spontaneous report was received from a female patient of unknown age. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, frequency, route of administration and anatomical location were not provided) for prophylaxis. The patient reported that she had missed her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No adverse reactions were reported.
developed cellulitis from the vaccines; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), in Nov2022 as dose number unknown, single (Lot number: FW6029) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CELLULITIS (medically significant) with onset Nov2022, outcome "unknown", described as "developed cellulitis from the vaccines".; Sender's Comments: A possibly contributory role of PREVNAR 20 in triggering the onset of CELLULITIS cannot be fully excluded, considering the temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-PV202200115716 same reporter, drug and event, different patient;
On (Dated) tested positive for Covid; On (Dated) tested positive for Covid; On (Dated) tested positive for Covid; Felt run down; This is a spontaneous report from a contactable other health professional (HCP). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at a single dose (first dose) for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got her first dose on 28Dec2020 and on 07Jan2021, she felt run down so she decided to get tested for COVID. On 09Jan2021, she tested positive for COVID. Her second dose is due 18Jan2021 and she needed to know if it is ok for her to get her second dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 09Jan2021. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (tested positive for COVID) with BNT162b2 can not be completely excluded.
Started having Chest pain, SOA, body aches, fatigue, HA, chills, fever (100.1), and diaphoresis after second COVID vaccine was seen in ER on 2/3/21. Diagnosed with chest pain, fever, and adverse effect of vaccine.
On 10.15.22 I began feeling shortness of breath doing housework.  On the morning of 10.16.22 I was experiencing extreme trouble breathing and elevated heart rate.  I went the the ER and discovered I had numerous PEs in both lungs.  (Blood clots in my lungs)  I was admitted to the hospital and spent 7 days on IV Heparin and Oxygen to treat the clots. I have no family history of clotting.  My blood is being tested for genetic factors.  I have not received results yet.